Cited by 188Global Cancer Incidence and ScreeningProstate Cancer Diagnosis and TreatmentLung Cancer Diagnosis and Treatment

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Trends in Metastatic Breast and Prostate Cancer — Lessons in Cancer Dynamics

Welch, H. Gilbert, Gorski, David H., Albertsen, Peter C.·2015·New England Journal of Medicine

DOI 10.1056/nejmp1510443

Open this paper in CoChat — free account

Abstract

Interview with Dr. H. Gilbert Welch on trends in the incidence of metastatic cancers and their implications for both screening and our understanding of cancer. (06:57)Download Discordant trends in the incidence of metastatic breast and prostate cancer since the widespread implementation of early-detection efforts may reflect distinct disease dynamics or may result from the different screening strategies used.

Integrity signals

Registry

Crossref · 10.1056/nejmp1510443

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prostate-Cancer Mortality at 11 Years of Follow-up
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., KWIATKOWSKI, M. K., Lujan, M., Lilja, H. G., Zappa, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113135 · Cited by 1,241
Impact of Follow-up Testing on Survival and Health-Related Quality of Life in Breast Cancer Patients
Ghezzi, P. (1994) · JAMA · doi:10.1001/jama.1994.03510440047031 · Cited by 618
Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
Welch, H. G., & Albertsen, P. C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp278 · Cited by 578
Self-citation
Karnofsky Memorial Lecture. Natural history of small breast cancers.
Hellman, S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2229 · Cited by 414
TEMPORAL TRENDS IN RATES OF PROSTATE CANCER: DECLINING INCIDENCE OF ADVANCED STAGE DISEASE, 1974 TO 1994
Newcomer, L. M., Stanford, J. L., Blumenstein, B. A., & Brawer, M. K. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64231-9 · Cited by 158

Show all 5 references

Sorted by citations

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,685
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
Welch, H. G., Prorok, P. C., O’Malley, A. J., & Kramer, B. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600249 · Cited by 698
Self-citation
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Trends in Incidence of Metastatic Prostate Cancer in the US
Desai, M. M., Cacciamani, G. E., Gill, K. S., Zhang, J., Liu, L., Abreu, A. L., & Gill, I. S. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.2246 · Cited by 247
Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States
Kelly, S. P., Anderson, W. F., Rosenberg, P. S., & Cook, M. B. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.10.014 · Cited by 217
Epidemiologic Signatures in Cancer
Welch, H. G., Kramer, B. S., & Black, W. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1905447 · Cited by 213
Self-citation
Molecular characterization of breast cancer CTCs associated with brain metastasis
Boral, D., Vishnoi, M., Liu, H. N., Yin, W., Sprouse, M. L., Scamardo, A. T., Hong, D. S., Tan, T. Z., Thiery, J. P., Chang, J. C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00196-1 · Cited by 191
Reconsidering Prostate Cancer Mortality — The Future of PSA Screening
Welch, H. G., & Albertsen, P. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmms1914228 · Cited by 180
Self-citation
Mammography screening: A major issue in medicine
Autier, P., & Boniol, M. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.11.002 · Cited by 189
Population-based screening for cancer: hope and hype
Shieh, Y., Eklund, M., Sawaya, G. F., Black, W. C., Kramer, B. S., & Esserman, L. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.50 · Cited by 152
Prostate Cancer Screening — A Perspective on the Current State of the Evidence
Pinsky, P. F., Prorok, P. C., & Kramer, B. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmsb1616281 · Cited by 124
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012
Pang, H., Wang, X., Stinchcombe, T. E., Wong, M. L., Cheng, P., Ganti, A. K., Sargent, D. J., Zhang, Y., Hu, C., Mandrekar, S. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.7088 · Cited by 118
Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA
Schafer, E. J., Jemal, A., Wiese, D., Sung, H., Kratzer, T. B., Islami, F., Dahut, W. L., & Knudsen, K. E. (2023) · European Urology · doi:10.1016/j.eururo.2022.11.023 · Cited by 114
A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE)
Anttinen, M., Ettala, O. O., Malaspina, S., Jambor, I., Sandell, M., Kajander, S. A., Rinta-Kiikka, I. C., Schildt, J., Saukko, E., Rautio, P., et al. (2020) · European Urology Oncology · doi:10.1016/j.euo.2020.06.012 · Cited by 121
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer
Preston, M. A., Batista, J. L., Wilson, K. M., Carlsson, S., Gerke, T. A., Sjoberg, D. D., Dahl, D. M., Sesso, H. D., Feldman, A. S., Gann, P. H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7527 · Cited by 111
Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer de la prostate
Rozet, F., Hennequin, C., Beauval, J., Beuzeboc, P., Cormier, L., Fromont, G., Mongiat-Artus, P., Ouzzane, A., Ploussard, G., Azria, D., et al. (2016) · The French Journal of Urology · doi:10.1016/s1166-7087(16)30705-9 · Cited by 114
Trends in the Incidence of Fatal Prostate Cancer in the United States by Race
Kelly, S. P., Rosenberg, P. S., Anderson, W. F., Andreotti, G., Younes, N., Cleary, S. D., & Cook, M. B. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.011 · Cited by 106
Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts
Helgstrand, J. T., Røder, M. A., Klemann, N., Toft, B. G., Lichtensztajn, D. Y., Brooks, J. D., Brasso, K., Vainer, B., & Iversen, P. (2018) · Cancer · doi:10.1002/cncr.31384 · Cited by 103
Epidemiology of De Novo Metastatic Breast Cancer
Daily, K. C., Douglas, E. H., Romitti, P. A., & Thomas, A. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.01.017 · Cited by 94
Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography
Vlahiotis, A., Griffin, B., Stavros, A. T., & Margolis, J. M. (2018) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s150260 · Cited by 81
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Moschini, M., Carroll, P. R., Eggener, S. E., Epstein, J. I., Graefen, M., Montironi, R., & Parker, C. C. (2017) · European Urology · doi:10.1016/j.eururo.2017.03.009 · Cited by 80
De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype
Press, D. J., Miller, M. E., Liederbach, E., Yao, K. A., & Huo, D. (2017) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9871-9 · Cited by 74
NUSAP1 promotes invasion and metastasis of prostate cancer
Gordon, C. A., Gong, X., Ganesh, D., & Brooks, J. D. (2017) · Oncotarget · doi:10.18632/oncotarget.15604 · Cited by 72
Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis
Seisen, T., Vetterlein, M. W., Karabon, P., Jindal, T., Sood, A., Nocera, L., Nguyen, P. L., Choueiri, T. K., Trinh, Q., Menon, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.08.011 · Cited by 74
Prostate cancer screening and treatment: where have we come from and where are we going?
Albertsen, P. C. (2020) · British Journal of Urology · doi:10.1111/bju.15153 · Cited by 70
Self-citation
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy
Puliti, D., Bucchi, L., Mancini, S., Paci, E., Baracco, S., Campari, C., Canuti, D., Cirilli, C., Collina, N., Conti, G. M., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.030 · Cited by 67
Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cells
Phannasil, P., Ansari, I. H., Azzouny, M. E., Longacre, M. J., Rattanapornsompong, K., Burant, C., MacDonald, M. J., & Jitrapakdee, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.021 · Cited by 66
Secondary data sources for health services research in urologic oncology
Cole, A. P., Friedlander, D. F., & Trinh, Q. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.08.008 · Cited by 61
MgO nanoparticles coated with polyethylene glycol as carrier for 2-Methoxyestradiol anticancer drug
Alfaro, A., León, A. M., Guajardo-Correa, E., Reuquén, P., Torres, F. J., Mery, M. F., Segura, R., Zapata, P. A., & Orihuela, P. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214900 · Cited by 61
Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population
Li, T., Chu, L. K., Wang, L. I., Moy, L. M., Brammer, M. G., Song, C., Green, M. C., Kurian, A. W., Gomez, S. L., & Clarke, C. A. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0791-9 · Cited by 60
Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
Cabarkapa, S., Perera, M., McGrath, S. M., & Lawrentschuk, N. (2016) · Prostate International · doi:10.1016/j.prnil.2016.09.002 · Cited by 60
Characterization of Differences Between Prostate Cancer Patients Presenting With De Novo Versus Primary Progressive Metastatic Disease
Finianos, A. N., Gupta, K., Clark, B., Simmens, S. J., & Aragon‐Ching, J. B. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.08.006 · Cited by 60
Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening
Machens, A., & Dralle, H. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0325 · Cited by 58
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases
Bernstein, A., Shoag, J. E., Golan, R., Halpern, J. A., Schaeffer, E. M., Hsu, W.-C., Nguyen, P. L., Sedrakyan, A., Chen, R. C., Eggener, S. E., et al. (2017) · The Journal of Urology · doi:10.1016/j.juro.2017.12.048 · Cited by 56
Statistics and pitfalls of trend analysis in cancer research: a review focused on statistical packages
Xu, J., Lin, Y., Yang, M., & Zhang, L. (2020) · Journal of Cancer · doi:10.7150/jca.43521 · Cited by 46
Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses
Dalela, D., Sun, M., Díaz, M., Karabon, P., Seisen, T., Trinh, Q., Menon, M., & Abdollah, F. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.04.012 · Cited by 46
Diagnostic characteristics of lethal prostate cancer
Helgstrand, J. T., Røder, M. A., Klemann, N., Toft, B. G., Brasso, K., Vainer, B., & Iversen, P. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.007 · Cited by 46
Overview of guidelines on breast screening: Why recommendations differ and what to do about it
Jørgensen, K. J., Kalager, M., Barratt, A. L., Baines, C. J., Zahl, P., Brodersen, J., & Harris, R. (2016) · The Breast · doi:10.1016/j.breast.2016.08.002 · Cited by 44
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
Lam, D., Clark, S. J., Stirzaker, C., & Pidsley, R. (2020) · Cancers · doi:10.3390/cancers12102993 · Cited by 43
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men
Basourakos, S. P., Gulati, R., Vince, R., Spratt, D. E., Lewicki, P., Hill, A., Nyame, Y. A., Cullen, J., Markt, S. C., Barbieri, C. E., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200031 · Cited by 42
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis
Meglio, A. D., Freedman, R. A., Lin, N., Barry, W. T., Metzger, O., Keating, N. L., King, T. A., Sertoli, M. R., Boccardo, F., Winer, E. P., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3845-5 · Cited by 42
The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer
Seltzer, S., Corrigan, M. A., & O’Reilly, S. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104404 · Cited by 41
Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
Heller, D. R., Chiu, A. S., Farrell, K., Killelea, B. K., & Lannin, D. R. (2019) · Cancers · doi:10.3390/cancers11040500 · Cited by 38
Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement
Sundaresan, V. M., Smani, S., Rajwa, P., Renzulli, J., Sprenkle, P. C., Kim, I. Y., & Leapman, M. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.06.003 · Cited by 36
Use of the 4Kscore test to predict the risk of aggressive prostate cancer prior to prostate biopsy: Overall cost savings and improved quality of care to the us healthcare system.
Voigt, J. D., Dong, Y., Linder, V., & Zappala, S. M. (2017) · PubMed Central · doi:10.3909/riu0753 · Cited by 36
Truth or Spin? Disease Definition in Cancer Screening
Reid, L. (2017) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhx006 · Cited by 35
A Content Analysis of Nonprofit Hospital Community Health Needs Assessments and Community Benefit Implementation Strategies in Philadelphia
Powell, R. E., Doty, A. M. B., Rising, K. L., Karp, D. N., Baehr, A., & Carr, B. G. (2017) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000621 · Cited by 28
Trends in cancer incidence and mortality rates in the United States from 1975 to 2016
Yang, R., Zhou, Y., Wang, Y., Du, C., & Wu, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-7841 · Cited by 31
Overdiagnosis in urologic cancer
Klotz, L. H. (2021) · World Journal of Urology · doi:10.1007/s00345-020-03523-2 · Cited by 30
Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
File, D. M., Pascual, T., Deal, A. M., Wheless, A., Perou, C. M., Dees, E. C., & Carey, L. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06700-6 · Cited by 29
Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm
Halpern, J. A., Shoag, J. E., Mittal, S., Oromendia, C., Ballman, K. V., Hershman, D. L., Wright, J. D., Shih, Y. T., Nguyen, P. L., & Hu, J. C. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.08.092 · Cited by 27
Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice
Gaylis, F. D., Choi, J. E., Hamilton, Z. A., Dato, P. E., Cohen, E. S., Calabrese, R., Prime, H., Rosenbaum, A., & Kader, A. K. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.06.059 · Cited by 25
Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography
Jacklyn, G., McGeechan, K., Irwig, L., Houssami, N., Morrell, S. L., Bell, K., & Barratt, A. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4443-x · Cited by 25
Impact of Nanomedicine in Women's Metastatic Breast Cancer
Ashkarran, A. A., Lin, Z., Rana, J., Bumpers, H. L., Sempere, L. F., & Mahmoudi, M. (2023) · Small · doi:10.1002/smll.202301385 · Cited by 23
Tissue-based biomarkers in prostate cancer
Clinton, T. N., Bagrodia, A., Lotan, Y., Margulis, V., Raj, G. V., & Woldu, S. L. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1372687 · Cited by 23
Cancer Screening, Incidental Detection, and Overdiagnosis
Welch, H. G., & Bergmark, R. W. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad127 · Cited by 22
Self-citation
Role of surgery in oligometastatic prostate cancer
Jenjitranant, P., & Touijer, K. A. (2019) · Prostate International · doi:10.1016/j.prnil.2019.10.001 · Cited by 19
A zwitterionic near-infrared dye linked TrkC targeting agent for imaging metastatic breast cancer
Yang, Z., Usama, S. M., Li, F., Burgess, K., & Li, Z. (2018) · MedChemComm · doi:10.1039/c8md00190a · Cited by 20
Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer
Gómez‐Gómez, E., Jiménez‐Vacas, J. M., Carrasco‐Valiente, J., Herrero‐Aguayo, V., Blanca, A., León‐González, A. J., Valero-Rosa, J., Fernández-Rueda, J. L., González-Serrano, T., López‐Miranda, J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13845 · Cited by 18
Metastatic breast cancer: The Odyssey of personalization
Sonnenblick, A., Ponde, N. F., & Piccart, M. J. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.07.002 · Cited by 18
European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance
Gómez‐Gómez, E., Carrasco‐Valiente, J., Blanca, A., Barco-Sánchez, B., Fernández-Rueda, J. L., Molina‐Abril, H., Valero-Rosa, J., Font, P., & Requena-Tapia, M. J. (2016) · Urology · doi:10.1016/j.urology.2016.11.004 · Cited by 18
Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment
Labbate, C. V., Klotz, L. H., Morrow, M., Cooperberg, M. R., Esserman, L. J., & Eggener, S. E. (2022) · The Journal of Urology · doi:10.1097/ju.0000000000002972 · Cited by 18
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer
Gómez‐Gómez, E., Jiménez‐Vacas, J. M., Pedraza‐Arévalo, S., L‐López, F., Herrero‐Aguayo, V., Hormaechea‐Agulla, D., Valero-Rosa, J., Ibáñez‐Costa, A., León‐González, A. J., Sánchez‐Sánchez, R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091400 · Cited by 17
Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
Che, W., Liu, J., Fu, T., Wang, X., & Lyu, J. (2022) · Current Oncology · doi:10.3390/curroncol29110660 · Cited by 18
Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer
Machens, A., Lorenz, K., Brandenburg, T., Führer, D., Weber, F., & Dralle, H. (2024) · Cancers · doi:10.3390/cancers16050917 · Cited by 17
PSA screening for prostate cancer
Sadi, M. V. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.08.722 · Cited by 17
Survival after recurrence of stage I–III breast, colorectal, or lung cancer
Hassett, M. J., Uno, H., Cronin, A. M., Carroll, N. M., Hornbrook, M. C., Fishman, P. A., & Ritzwoller, D. P. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.07.001 · Cited by 16
Progress in Low Dose Rate Brachytherapy for Prostate Cancer
McLaughlin, P. W., & Narayana, V. (2019) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.08.002 · Cited by 16
An Expanded Agenda for the Primary Prevention of Breast Cancer: Charting a Course for the Future
White, M. C., Kavanaugh-Lynch, M. (. H. E., Davis-Patterson, S., & Buermeyer, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030714 · Cited by 17
The history of cancer screening
Jatoi, I., Anderson, W. F., Miller, A. B., & Brawley, O. W. (2019) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2018.12.006 · Cited by 15
Deceptive measures of progress in the NHS long-term plan for cancer: case-based vs. population-based measures
Oke, J. L., Brown, S. J., Senger, C., & Welch, H. G. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02308-9 · Cited by 15
Self-citation
Disparities in receipt of 1-st line CDK4/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast cancer in the real-world setting
Pilehvari, A., Kimmick, G. G., You, W., Bonilla, G., & Anderson, R. T. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01902-w · Cited by 14
Prostate cancer screening in Brazil: should it be done or not?
Busato, W. F. S., & Almeida, G. L. (2016) · International braz j urol · doi:10.1590/s1677-5538.ibju.2015.0709 · Cited by 14
Suppression of SIN3A by miR-183 Promotes Breast Cancer Metastasis
Davenport, M. L., Davis, M. R., Davenport, B. N., Crossman, D. K., Hall, A., Pike, J., Harada, S., Hurst, D. R., & Edmonds, M. D. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0508 · Cited by 14
The Precision Prostatectomy: “Waiting for Godot”
Sood, A., Abdollah, F., Jeong, W., & Menon, M. (2020) · European Urology Focus · doi:10.1016/j.euf.2020.01.010 · Cited by 14
Hypoxia enhances motility and EMT through the Na+/H+ exchanger NHE-1 in MDA-MB-231 breast cancer cells
Takatani‐Nakase, T., Matsui, C., Hosotani, M., Omura, M., Takahashi, K., & Nakase, I. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.113006 · Cited by 13
Mohs Micrographic Surgery for Melanoma
Brodland, D. G. (2022) · Dermatologic Clinics · doi:10.1016/j.det.2022.07.008 · Cited by 13
Breast Cancer, Chemokines, And Metastasis: A Search for Decoy Ligands of the CXCR4 Receptor
Mizejewski, G. J. (2018) · Journal of Neoplasms · doi:10.14302/issn.2639-1716.jn-18-2208 · Cited by 13
Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program
Cole, A. P., Krasnova, A., Ramaswamy, A., Fletcher, S. A., Friedlander, D. F., McNabb-Baltar, J. Y., Melnitchouk, N., Lipsitz, S. R., Sun, M., Kibel, A. S., et al. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00352 · Cited by 13
Overdiagnosis in the Age of Digital Cancer Screening
Brawley, O. W., & Paller, C. J. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa081 · Cited by 13
Prostate Cancer Prevention: Concepts and Clinical Trials
Hamilton, Z. A., & Parsons, J. K. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0587-1 · Cited by 13
Genomic Characterization of De Novo Metastatic Breast Cancer
Mullangi, S., & Vasan, N. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.11.005 · Cited by 12
The evolving role of receptors as predictive biomarkers for metastatic breast cancer
Martínez-Pérez, C., Turnbull, A., & Dixon, J. M. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1552138 · Cited by 13
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer
Yang, J., Yin, H. X., Yang, J., Wei, Y., Fang, L., Chai, D., Zhang, Q., & Zheng, J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.12.002 · Cited by 12
Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer
Moschini, M., Shariat, S. F., Freschi, M., Soria, F., Abufaraj, M. M., Gandaglia, G., Dell’Oglio, P., Mattei, A., Damiano, R., Salonia, A., et al. (2017) · Urologia Internationalis · doi:10.1159/000454736 · Cited by 11
Correcting a decade of negative news about mammography
Schattner, E. J. (2019) · Clinical Imaging · doi:10.1016/j.clinimag.2019.03.011 · Cited by 12
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence
Conte, B., Soldato, D., Razeti, M. G., Fregatti, P., de Azambuja, E., Schettini, F., Prat, A., Mastro, L. D., & Lambertini, M. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.10.001 · Cited by 13
POINT: Should Only Primary Care Physicians Provide Shared Decision-making Services to Discuss the Risks/Benefits of a Low-Dose Chest CT Scan for Lung Cancer Screening? Yes
Goodson, J. D. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.11.057 · Cited by 11
The Breast Cancer Screening “Arcade” and the “Whack-A-Mole” Efforts to Reduce Access to Screening
Kopans, D. B. (2017) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2017.06.002 · Cited by 11
The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment
Hewitt, K. C., Son, J. D., Glencer, A., Borowsky, A. D., Cooperberg, M. R., & Esserman, L. J. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0110 · Cited by 11
Integrative Bioinformatics Analysis Reveals That miR-524-5p/MEF2C Regulates Bone Metastasis in Prostate Cancer and Breast Cancer
Tian, Q., Lu, Y., Yan, B.-C., & Wu, C.-G. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/5211329 · Cited by 10
Impacts on functional and oncological outcomes of Robotic-assisted Radical Prostatectomy 10 years after the US Preventive Service Taskforce recommendations against PSA screening
Moschovas, M. C., Abdel, J., Saikali, S., Sandri, M. F., Bhat, S., Rogers, T., Gamal, A., Loy, D., Patel, E., Reddy, S. K., et al. (2024) · International braz j urol · doi:10.1590/s1677-5538.ibju.2023.0530 · Cited by 10
What's new in screening in 2015?
Carlsson, S., & Roobol, M. J. (2016) · Current Opinion in Urology · doi:10.1097/mou.0000000000000321 · Cited by 10
The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients
Moschini, M., Soria, F., Briganti, A., & Shariat, S. F. (2016) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2016.52 · Cited by 10
Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer
Meyer, A. R., Joice, G. A., Allaf, M. E., Rowe, S. P., & Gorin, M. A. (2018) · Current Opinion in Urology · doi:10.1097/mou.0000000000000549 · Cited by 10
Trends in Metastatic Breast and Prostate Cancer.
Eby, P. R. (2016) · PubMed · doi:10.1056/nejmc1515983 · Cited by 9
Self-citation
Who and when should we screen for prostate cancer? Interviews with key opinion leaders
Carlsson, S., Leapman, M. S., Carroll, P. R., Schröder, F. H., Albertsen, P. C., Ilić, D., Barry, M. J., Frosch, D. L., & Vickers, A. J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0526-x · Cited by 9
Self-citation
New agents for the management of resistant metastatic breast cancer
Anampa, J., & Sparano, J. A. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409206 · Cited by 8
Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer Patients
Sun, M., Lin, F., Chen, L.-J., Li, H., Lin, W., Du, H., Yang, X., & Li, M. (2021) · Current Oncology · doi:10.3390/curroncol28040214 · Cited by 8

Authors: Welch, H. G., Gorski, D. H., & Albertsen, P. C.
Affiliations: Dartmouth Institute for Health Policy and Clinical Practice (US)
ORCID: Welch, H. Gilbert
Gorski, David H.
Albertsen, Peter C.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-10-29
Volume: 373
Issue: 18
Pages: 1685-1687
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmp1510443
OpenAlex: W2288757641
Cited by: 188
References: 5
Citations by year: 2026: 3 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 15 · 2021: 11 · 2020: 18 · 2019: 18 · 2018: 19 · 2017: 39 · 2016: 37 · 2015: 2
FWCI: 14.13
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords: metastatic breast cancer, metastatic prostate cancer, cancer incidence trends, cancer screening, early detection, disease dynamics
MeSH terms: Adult, Breast Neoplasms, Female, Humans, Male, Mammography, Middle Aged, Neoplasm Metastasis, Prostatic Neoplasms, United States, Incidence, Prostate-Specific Antigen, SEER Program, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trends in Metastatic Breast and Prostate Cancer — Lessons in Cancer Dynamics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks